申请人:TAISHO PHARMACEUTICAL CO. LTD
公开号:EP0765875A1
公开(公告)日:1997-04-02
Object: To provide compounds useful as inhibitors of blood platelet aggregation for intravenous administration.
Constitution: A thiazoline derivative represented by the formula:
[wherein R1 is a hydroxyl group, an alkoxy group, a cycloalkoxy group or a group represented by the formula: R4NH- (wherein R4 is a cycloalkyl group), R2 is an alkyl group, a cycloalkyl group or a phenylalkyl group, R3 is a hydrogen atom or an alkyl group, and n is an integer of 2 to 9] or a salt thereof.
目的提供可作为血小板聚集抑制剂用于静脉注射的化合物。
组成:一种噻唑啉衍生物,由式:
[其中 R1 是羟基、烷氧基、环烷氧基或由式表示的基团:R4NH-(其中 R4 为环烷基),R2 为烷基、环烷基或苯烷基,R3 为氢原子或烷基,n 为 2 至 9 的整数]或其盐。